In hospital mortality of ST segment elevation myocardial infarction treated with primary angioplasty: Monocentric Tunisian study of 250 patients

##plugins.themes.academic_pro.article.sidebar##

Published Nov 14, 2013
Download
pdf
Vol. 91 No. 10 (2013): Issue Oct 2013

##plugins.themes.academic_pro.article.main##

Wissem Sdiri
Dorra Mbarek
Hédi Ben Slima
Rami Tlili
Selma Longo
Youssef Ben Ameur
Mohamed Rachid Boujnah

Abstract

Background: Myocardial reperfusion is the « corner stone » in the treatment of myocardial infarction. Primary percutaneous coronary intervention has proved its superiority upon intravenous thrombolysis.
aim: To evaluate in hospital mortality of acute myocardial infarction treated with primary angioplasty and to determine its predictive factors.
methods:We performed a retrospective study including 250 patients admitted to Mongi Slim university Hospital at la Marsa between January the 1st, 2006 and June the 30th, 2011. All these patients had an ST segment elevation myocardial infarction and underwent primary percutaneous coronary intervention within 24 hours after symptom onset.
results: In our study, males were predominant with a sex-ratio of 4.55. Our patients were aged 59.8± 11.19 years old. Diabetes mellitus was present in 42% of our population. In 60.4% of the cases, myocardial infarction was located in the anterior wall. Cardiogenic shock was present in 13.6% of patients. The culprit coronary artery was the left anterior descending artery in 57.6% of the cases. The coronary flow in the culprit artery was TIMI 0 in 64% of the patients and TIMI 1 in 13.2% of the patients. Angiographic success (TIMI 3 flow and residual stenosis <20%) was achieved in 84% of cases. Our in-hospital mortality rate (cardiogenic shock excluded) was 6.9%.
Predictive factors of in-hospital mortality were: female gender, diabetes mellitus, hypertension, renal failure, multi-vessel lesion,TIMI flow before percutaneous coronary intervention, proximal left anterior descending artery lesion, initial cardiogenic shock and acute stent thrombosis.
Conclusion: In our local context, primary percutaneous coronary intervention is an efficient and safe treatment of myocardial infarction with persistent ST-segment elevation.

Keywords:

primary coronary intervention, coronary stent, acute myocardial infarction.

##plugins.themes.academic_pro.article.details##

References

  1. Kushner FG, Hand M, Smith Jr SC, et al. 2009 Focused Updates: ACC/AHA Guidelines for the management of patients with STElevation myocardial infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2009; 54:2205-24.
  2. Keeley EC, Hillis LD. Primary PCI for myocardial infarction with ST-segment elevation. N Engl J Med 2007;356:47-54.
  3. Ko DT, Donovan LR, Huynh T, et al. A survey of primary percutaneous coronary intervention for patients with ST segment elevation myocardial infarction in Canadian hospitals. Can J Cardiol 2008; 24:839-43.
  4. Bonnefoy E, Steg PG, Boutitie F, et al. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow up. Eur Heart J 2009; 30:1598-606.
  5. Widimsky P, Bilkova D, Penicka M, et al. Long-term outcomes of patients with acute myocardial infarction presenting to hospitals without catheterization laboratory and randomized to immediate thrombolysis or interhospital transport for primary percutaneous coronary intervention. Five years' follow-up of the PRAGUE-2 trial. Eur Heart J 2007; 28:679-84.
  6. Busk M, Maeng M, Rasmussen K, et al. The Danish multicentre randomized study of fibrinolytic therapy vs. primary angioplasty in acute myocardial infarction (the DANAMI-2 trial): outcome after 3 years follow-up. Eur Heart J 2008; 29:1259-66.
  7. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993; 3238:673-8.
  8. Klein LW, Block P, Brindis RG, et al. Percutaneous coronary interventions in octogenarians in the American College of Cardiology-National Cardiovascular data registry: development of a nomogram predictive of in-hospital mortality. J Am Coll Cardiol 2002; 40:394-402.
  9. De Boer MJ, Ottervanger JP, J van't Hof AW, et al. Reperfusion therapy in elderly patients with acute myocardial infarction. J Am Coll Cardiol 2002; 39:1723-8.
  10. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011; 5:44-122.
  11. Tiefenbrunn AJ, Chandra NC, Frensh WJ, Gore JM, Rogers WJ. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (rt-PA) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction. J Am Coll Cardiol 1998; 31:1240-5.
  12. Garcia E, Elizaga J, Perez-Castellano N, et al. Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction. J Am Coll Cardiol 1999; 33:605-11.
  13. Ribeiro EE, Silva LA, Carneiro R, et al. Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol 1993; 22:376-80.
  14. Every NR, Parsons LS, Hlatky M, Martin JS, Weaver WD. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. Myocardial Infarction Triage and Intervention Investigators. N Engl J Med 1996; 335:1253-60.
  15. O'Keefe JH, Beiley WL, Rutherford BD, Hartzler GO. Primary angioplasty for acute myocardial infarction in 1000 consecutive patients: results in an unselected population and high-risk subgroups. Am J Cardiol 1993; 72:107-15.
  16. Hannan EL, Racz MJ, Arani DT, Ryan TJ, Walford G, McCallister BD. Short and long-term mortality for patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2000; 36:1194-201.
  17. Mahjoub Hichem. Facteurs prédictifs du prognostic intrahospitalier des angioplasties a la phase aigue de l'infarctus du myocarde. A propos de 208 cas. Thèse Med Tunis 2008.
  18. Chaaoua Kilani. Revascularisation en urgence par angioplastie transcutanée au cours du syndrome coronarien aigu avec sus décalage du segment ST. Résultats immédiats et à moyen terme. A propos de 106 patients. Thèse Med Tunis 2005.
  19. Mghaieth F, Aloui H, Chabrak S, et al. Inhospital prognosis of acute myocardial infarction : comparison of two periods to ten years of interval. Ann Cardiol Angeiol 2006; 55:241-5.
  20. Cambou JP, Danchin N, Boutalbi Y, et al. Evolution of the management and outcomes of patients admitted for acute myocardial infarction in France from 1995 to 2000: data from the USIK 1995 and USIC 2000 nationwide registries. Ann Cardiol Angeiol 2004; 53:12-17.
  21. Reynolds HR, Farkouh ME, Lincoff AM, et al. Impact of female sex on death and bleeding after fibrinolytic treatment of myocardial infarction in Gusto V. Arch Intern Med 2007; 167:2054-60.
  22. D'Ascenzo F, Gonella A, Quadri G, et al. Comparison of mortality rates in women versus men presenting with ST-segment elevation myocardial infarction. Am J Cardiol 2011; 107:651-4.
  23. Valente S, Lazzeri C, Chiostri M, et al. Gender-related difference in ST-elevation myocardial infarction treated with primary angioplasty: a single-centre 6-year registry. Eur J Prev Cardiol 2012; 19:233-40.
  24. Vakili BA, Kaplan RC, Brown DL. Sex-based differences in early mortality of patients undergoing primary angiolpasty for first acute myocardial infarction. Circulation 2001; 104:3034-8.
  25. Urban P, Stauffer JC, Bleed D, et al. A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock- (S) MASH. Eur Heart J 1999; 20:1030-8.
  26. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 1999; 341:625-34.